The GI side effects are dose-dependent
Weight loss follows a progressive pattern, with 35% reduction by 12 weeks and potentially 1015% or more by 612 months in responders
Offer excludes tax and is subject to change
You might pause dose increases, return to a lower dose, or try switching to a different medication altogether
In particular, the first study demonstrated that, along with improvements in anthropometric parameters, HOMA-IR reduced in both treatment arms, but liraglutide 1.2 mg/day was superior to metformin also in reducing glucose levels at 120 min during OGTT [57]
Diabetic mice developed more severe infections, experienced greater weight loss and higher viral loads, and showed increased activity of a fibrosis-related gene not observed in non-diabetic mice